Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Bypass | 57 | 2021 | 2189 | 4.270 |
Why?
|
Heart Valve Prosthesis Implantation | 47 | 2021 | 1555 | 3.600 |
Why?
|
Heart Valve Prosthesis | 31 | 2021 | 1469 | 2.880 |
Why?
|
Mitral Valve | 34 | 2020 | 1471 | 2.710 |
Why?
|
Bioprosthesis | 17 | 2018 | 593 | 2.520 |
Why?
|
Heart Valve Diseases | 27 | 2021 | 1037 | 2.430 |
Why?
|
Cardiac Surgical Procedures | 30 | 2022 | 3630 | 2.340 |
Why?
|
Endocarditis | 7 | 2021 | 350 | 2.070 |
Why?
|
Aortic Valve | 41 | 2021 | 1961 | 1.970 |
Why?
|
Endocarditis, Bacterial | 7 | 2021 | 444 | 1.720 |
Why?
|
Endarterectomy | 5 | 2013 | 196 | 1.410 |
Why?
|
Mitral Valve Insufficiency | 12 | 2019 | 1404 | 1.290 |
Why?
|
Heart Neoplasms | 6 | 2020 | 362 | 1.290 |
Why?
|
Heart Arrest, Induced | 11 | 2019 | 359 | 1.240 |
Why?
|
Saphenous Vein | 4 | 2014 | 518 | 1.110 |
Why?
|
Aortic Valve Stenosis | 17 | 2020 | 2009 | 0.990 |
Why?
|
Cardiopulmonary Bypass | 24 | 2018 | 1094 | 0.950 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 3 | 2020 | 38 | 0.870 |
Why?
|
Coronary Artery Disease | 13 | 2020 | 6392 | 0.860 |
Why?
|
Postoperative Complications | 58 | 2021 | 15647 | 0.850 |
Why?
|
Atrial Fibrillation | 11 | 2018 | 5127 | 0.750 |
Why?
|
Myocardial Ischemia | 10 | 2021 | 2110 | 0.740 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2020 | 45 | 0.730 |
Why?
|
Paraganglioma | 2 | 2020 | 142 | 0.710 |
Why?
|
Reoperation | 35 | 2020 | 4302 | 0.660 |
Why?
|
Myocardial Revascularization | 8 | 2008 | 792 | 0.650 |
Why?
|
Aortic Aneurysm, Thoracic | 6 | 2012 | 696 | 0.640 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 2 | 2014 | 82 | 0.580 |
Why?
|
Poisons | 1 | 2017 | 38 | 0.560 |
Why?
|
Mammary Arteries | 4 | 2020 | 81 | 0.560 |
Why?
|
Embolectomy | 6 | 2018 | 129 | 0.540 |
Why?
|
Heart Atria | 3 | 2017 | 1346 | 0.540 |
Why?
|
Lidocaine | 2 | 2018 | 538 | 0.520 |
Why?
|
Potassium Compounds | 1 | 2015 | 42 | 0.510 |
Why?
|
Mitral Valve Annuloplasty | 2 | 2014 | 144 | 0.490 |
Why?
|
Graft Occlusion, Vascular | 3 | 2014 | 537 | 0.490 |
Why?
|
Femoral Artery | 2 | 2018 | 827 | 0.490 |
Why?
|
Disasters | 1 | 2021 | 519 | 0.480 |
Why?
|
Sternum | 11 | 2009 | 175 | 0.480 |
Why?
|
Coronary Vessels | 7 | 2018 | 3094 | 0.470 |
Why?
|
Intraoperative Complications | 5 | 2019 | 1165 | 0.460 |
Why?
|
Coronary Disease | 12 | 2004 | 5919 | 0.440 |
Why?
|
Treatment Outcome | 60 | 2021 | 64645 | 0.430 |
Why?
|
Aortic Valve Insufficiency | 6 | 2015 | 579 | 0.430 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1313 | 0.430 |
Why?
|
Humans | 199 | 2022 | 761326 | 0.430 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2015 | 169 | 0.430 |
Why?
|
Aorta | 7 | 2018 | 2042 | 0.420 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.410 |
Why?
|
Aortic Diseases | 5 | 2020 | 737 | 0.400 |
Why?
|
Aged | 117 | 2021 | 169179 | 0.400 |
Why?
|
Hypertension, Pulmonary | 2 | 2022 | 1580 | 0.400 |
Why?
|
Coronary Artery Bypass, Off-Pump | 2 | 2009 | 65 | 0.400 |
Why?
|
Hospital Mortality | 16 | 2021 | 5291 | 0.390 |
Why?
|
Aged, 80 and over | 72 | 2021 | 58946 | 0.390 |
Why?
|
Male | 149 | 2021 | 360621 | 0.390 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2015 | 2751 | 0.380 |
Why?
|
Aneurysm, False | 2 | 2012 | 254 | 0.380 |
Why?
|
Heart Arrest | 3 | 2015 | 1514 | 0.380 |
Why?
|
Heart Ventricles | 11 | 2021 | 3816 | 0.380 |
Why?
|
Coronary Aneurysm | 1 | 2014 | 232 | 0.380 |
Why?
|
Echocardiography, Transesophageal | 15 | 2019 | 1088 | 0.360 |
Why?
|
Leiomyoma | 1 | 2015 | 636 | 0.360 |
Why?
|
Middle Aged | 117 | 2021 | 220774 | 0.350 |
Why?
|
Postoperative Hemorrhage | 3 | 2018 | 415 | 0.340 |
Why?
|
Catheter Ablation | 3 | 2018 | 2752 | 0.340 |
Why?
|
Laser Therapy | 5 | 2004 | 1092 | 0.330 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 822 | 0.330 |
Why?
|
Heparin | 5 | 2015 | 1633 | 0.330 |
Why?
|
Ticlopidine | 5 | 2015 | 730 | 0.330 |
Why?
|
Retrospective Studies | 59 | 2021 | 80575 | 0.320 |
Why?
|
Female | 138 | 2021 | 392485 | 0.320 |
Why?
|
Myxoma | 2 | 2008 | 114 | 0.310 |
Why?
|
Time Factors | 32 | 2017 | 39974 | 0.300 |
Why?
|
Hemorrhage | 4 | 2015 | 3425 | 0.300 |
Why?
|
Heart Diseases | 2 | 2015 | 2785 | 0.300 |
Why?
|
Pulsatile Flow | 1 | 2009 | 321 | 0.300 |
Why?
|
Risk Factors | 47 | 2021 | 74152 | 0.290 |
Why?
|
Platelet Function Tests | 3 | 2015 | 271 | 0.290 |
Why?
|
Aortic Aneurysm | 5 | 2020 | 648 | 0.290 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2015 | 992 | 0.290 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1303 | 0.280 |
Why?
|
Prosthesis Design | 10 | 2018 | 2115 | 0.280 |
Why?
|
Cardiac Valve Annuloplasty | 2 | 2020 | 51 | 0.280 |
Why?
|
Hypothermia, Induced | 6 | 2005 | 756 | 0.280 |
Why?
|
Uterine Neoplasms | 1 | 2015 | 1420 | 0.270 |
Why?
|
Feeding Behavior | 1 | 2019 | 3187 | 0.270 |
Why?
|
Pulmonary Embolism | 6 | 2018 | 2566 | 0.270 |
Why?
|
Blood Vessel Prosthesis | 3 | 2005 | 954 | 0.270 |
Why?
|
Kaplan-Meier Estimate | 8 | 2018 | 6473 | 0.260 |
Why?
|
Length of Stay | 14 | 2021 | 6422 | 0.260 |
Why?
|
Anticoagulants | 4 | 2015 | 4813 | 0.260 |
Why?
|
Anastomosis, Surgical | 7 | 2012 | 983 | 0.260 |
Why?
|
Anemia | 1 | 2015 | 1508 | 0.260 |
Why?
|
Thoracic Surgical Procedures | 4 | 2020 | 348 | 0.250 |
Why?
|
Sternotomy | 2 | 2018 | 128 | 0.250 |
Why?
|
Postoperative Period | 7 | 2018 | 1813 | 0.250 |
Why?
|
Aorta, Thoracic | 5 | 2014 | 1097 | 0.250 |
Why?
|
Heart Valves | 4 | 2017 | 284 | 0.240 |
Why?
|
Angioplasty, Balloon, Coronary | 4 | 2005 | 1731 | 0.240 |
Why?
|
Receptors, Purinergic P2Y12 | 2 | 2015 | 115 | 0.240 |
Why?
|
Pipecolic Acids | 1 | 2004 | 77 | 0.230 |
Why?
|
Survival Rate | 27 | 2019 | 12710 | 0.230 |
Why?
|
Patient Selection | 6 | 2014 | 4244 | 0.220 |
Why?
|
Risk Assessment | 19 | 2019 | 23981 | 0.220 |
Why?
|
Blood Vessel Prosthesis Implantation | 4 | 2020 | 1427 | 0.220 |
Why?
|
Endoscopy | 2 | 2011 | 1851 | 0.210 |
Why?
|
Calcinosis | 5 | 2019 | 1469 | 0.210 |
Why?
|
Vascular Surgical Procedures | 6 | 2018 | 1490 | 0.210 |
Why?
|
Hypertension | 2 | 2022 | 8539 | 0.210 |
Why?
|
Purinergic P2Y Receptor Antagonists | 2 | 2015 | 284 | 0.210 |
Why?
|
Atrial Flutter | 2 | 2014 | 252 | 0.200 |
Why?
|
Creatine Kinase, MB Form | 2 | 2015 | 202 | 0.200 |
Why?
|
Follow-Up Studies | 26 | 2021 | 39108 | 0.200 |
Why?
|
Liver | 1 | 2017 | 7531 | 0.190 |
Why?
|
Thoracotomy | 4 | 2004 | 367 | 0.190 |
Why?
|
Axillary Artery | 2 | 1998 | 47 | 0.190 |
Why?
|
Stress, Physiological | 1 | 2009 | 1403 | 0.190 |
Why?
|
Blood Coagulation Disorders | 1 | 2004 | 350 | 0.190 |
Why?
|
Patient Discharge | 3 | 2013 | 3438 | 0.190 |
Why?
|
Electric Countershock | 2 | 2014 | 533 | 0.190 |
Why?
|
Lung Diseases, Interstitial | 2 | 2020 | 916 | 0.180 |
Why?
|
Health Facility Size | 1 | 2020 | 61 | 0.180 |
Why?
|
Thoracic Surgery | 2 | 2019 | 722 | 0.180 |
Why?
|
Echocardiography | 8 | 2020 | 4991 | 0.180 |
Why?
|
Angioplasty, Laser | 1 | 1999 | 18 | 0.170 |
Why?
|
Chordae Tendineae | 2 | 2019 | 39 | 0.170 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2014 | 773 | 0.170 |
Why?
|
Thrombolytic Therapy | 4 | 2018 | 2062 | 0.170 |
Why?
|
Embolism | 2 | 2002 | 400 | 0.170 |
Why?
|
Sequence Analysis, RNA | 5 | 2022 | 2019 | 0.170 |
Why?
|
Hospital Costs | 4 | 2020 | 948 | 0.170 |
Why?
|
Proportional Hazards Models | 11 | 2021 | 12450 | 0.170 |
Why?
|
RNA, Transfer | 1 | 2022 | 292 | 0.170 |
Why?
|
Antithrombin III | 2 | 2010 | 128 | 0.170 |
Why?
|
Thrombectomy | 1 | 2004 | 705 | 0.170 |
Why?
|
Texas | 1 | 2020 | 405 | 0.170 |
Why?
|
Stroke | 4 | 2021 | 9749 | 0.160 |
Why?
|
Hospital Bed Capacity | 1 | 2020 | 206 | 0.160 |
Why?
|
Survivors | 1 | 2009 | 2370 | 0.160 |
Why?
|
Databases, Factual | 8 | 2020 | 7954 | 0.160 |
Why?
|
Quality of Life | 2 | 2011 | 13355 | 0.160 |
Why?
|
Age Factors | 10 | 2018 | 18401 | 0.160 |
Why?
|
Atherosclerosis | 1 | 2014 | 3413 | 0.150 |
Why?
|
Adult | 65 | 2022 | 221122 | 0.150 |
Why?
|
Myocardial Infarction | 8 | 2012 | 11454 | 0.150 |
Why?
|
Sinus of Valsalva | 1 | 2018 | 60 | 0.150 |
Why?
|
Logistic Models | 12 | 2015 | 13251 | 0.150 |
Why?
|
Pericardium | 3 | 2017 | 675 | 0.150 |
Why?
|
Ventricular Dysfunction | 2 | 2009 | 144 | 0.150 |
Why?
|
Cardiac Output, Low | 2 | 1995 | 191 | 0.150 |
Why?
|
Incidence | 12 | 2021 | 21336 | 0.140 |
Why?
|
Survival Analysis | 17 | 2018 | 10075 | 0.140 |
Why?
|
Catheters | 1 | 2020 | 426 | 0.140 |
Why?
|
Thrombocytopenia | 1 | 2004 | 1179 | 0.140 |
Why?
|
Cerebrovascular Circulation | 3 | 2014 | 2727 | 0.140 |
Why?
|
Forecasting | 3 | 2021 | 2928 | 0.140 |
Why?
|
Boston | 9 | 2018 | 9333 | 0.140 |
Why?
|
Acute Coronary Syndrome | 1 | 2009 | 2191 | 0.140 |
Why?
|
Myocardium | 3 | 2021 | 4723 | 0.130 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2010 | 1723 | 0.130 |
Why?
|
Organ Preservation | 1 | 2019 | 382 | 0.130 |
Why?
|
Point-of-Care Systems | 2 | 2015 | 1212 | 0.130 |
Why?
|
Propensity Score | 4 | 2018 | 1908 | 0.130 |
Why?
|
Tachycardia, Sinus | 1 | 2015 | 42 | 0.130 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2020 | 355 | 0.130 |
Why?
|
Myeloproliferative Disorders | 1 | 2022 | 613 | 0.130 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 11900 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 7 | 2015 | 20555 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 1 | 2018 | 308 | 0.120 |
Why?
|
Lectins | 1 | 2017 | 491 | 0.120 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2015 | 108 | 0.120 |
Why?
|
Cerebrovascular Disorders | 4 | 1998 | 1475 | 0.120 |
Why?
|
Suture Techniques | 1 | 2020 | 771 | 0.120 |
Why?
|
Prosthesis-Related Infections | 3 | 1995 | 488 | 0.120 |
Why?
|
Constriction | 4 | 2002 | 171 | 0.120 |
Why?
|
Surgical Instruments | 2 | 2015 | 382 | 0.120 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2012 | 492 | 0.120 |
Why?
|
Blood Platelets | 2 | 2015 | 2481 | 0.120 |
Why?
|
Comorbidity | 7 | 2016 | 10498 | 0.110 |
Why?
|
Pituitary Apoplexy | 1 | 1994 | 29 | 0.110 |
Why?
|
Thrombosis | 2 | 2004 | 2942 | 0.110 |
Why?
|
Prosthesis Failure | 5 | 2013 | 1204 | 0.110 |
Why?
|
Learning Curve | 1 | 2015 | 230 | 0.110 |
Why?
|
Monitoring, Intraoperative | 2 | 1999 | 941 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2015 | 2119 | 0.110 |
Why?
|
Multivariate Analysis | 14 | 2015 | 12059 | 0.110 |
Why?
|
MicroRNAs | 2 | 2022 | 3796 | 0.110 |
Why?
|
Extracorporeal Circulation | 1 | 1993 | 182 | 0.100 |
Why?
|
Operating Rooms | 1 | 2019 | 790 | 0.100 |
Why?
|
Blood Transfusion | 3 | 2015 | 1299 | 0.100 |
Why?
|
Transplantation, Homologous | 4 | 2021 | 4810 | 0.100 |
Why?
|
Administration, Oral | 2 | 2014 | 4013 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 736 | 0.100 |
Why?
|
Cattle | 4 | 2013 | 3849 | 0.100 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2009 | 223 | 0.100 |
Why?
|
Life Support Care | 1 | 1993 | 226 | 0.100 |
Why?
|
Sex Characteristics | 3 | 2019 | 2637 | 0.100 |
Why?
|
Antithrombins | 1 | 2014 | 294 | 0.090 |
Why?
|
Heart Transplantation | 7 | 1995 | 3234 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2013 | 3419 | 0.090 |
Why?
|
Blood Coagulation | 2 | 2014 | 1154 | 0.090 |
Why?
|
Surgical Wound Infection | 2 | 2011 | 1525 | 0.090 |
Why?
|
Systole | 1 | 2013 | 937 | 0.090 |
Why?
|
Swine | 4 | 2013 | 5915 | 0.090 |
Why?
|
Preoperative Period | 2 | 2010 | 551 | 0.090 |
Why?
|
Aortography | 1 | 2012 | 420 | 0.090 |
Why?
|
Health Resources | 1 | 1996 | 935 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2017 | 1189 | 0.090 |
Why?
|
Cardiomyopathies | 2 | 2018 | 1964 | 0.080 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1997 | 1496 | 0.080 |
Why?
|
Perfusion | 1 | 2014 | 1374 | 0.080 |
Why?
|
Hodgkin Disease | 1 | 2017 | 1378 | 0.080 |
Why?
|
Drug Interactions | 1 | 2014 | 1415 | 0.080 |
Why?
|
Preoperative Care | 4 | 2010 | 2242 | 0.080 |
Why?
|
Recurrence | 8 | 2015 | 8470 | 0.080 |
Why?
|
Societies, Medical | 4 | 2014 | 3905 | 0.080 |
Why?
|
North America | 1 | 2012 | 1275 | 0.080 |
Why?
|
Heart-Lung Transplantation | 1 | 1989 | 87 | 0.080 |
Why?
|
Quantitative Trait Loci | 1 | 2017 | 2105 | 0.080 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2009 | 375 | 0.080 |
Why?
|
Angina, Unstable | 2 | 2005 | 888 | 0.080 |
Why?
|
Pacemaker, Artificial | 2 | 2004 | 808 | 0.080 |
Why?
|
Actuarial Analysis | 5 | 2005 | 374 | 0.070 |
Why?
|
Intraoperative Care | 3 | 2008 | 766 | 0.070 |
Why?
|
Troponin I | 2 | 2009 | 651 | 0.070 |
Why?
|
Intraoperative Period | 2 | 2013 | 511 | 0.070 |
Why?
|
Angina Pectoris | 2 | 2001 | 959 | 0.070 |
Why?
|
Cognition Disorders | 3 | 1999 | 3979 | 0.070 |
Why?
|
Cohort Studies | 10 | 2019 | 41440 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2021 | 3048 | 0.070 |
Why?
|
Aspirin | 3 | 2009 | 3134 | 0.070 |
Why?
|
Hemodynamics | 2 | 1995 | 4167 | 0.070 |
Why?
|
Emergencies | 4 | 2005 | 1217 | 0.070 |
Why?
|
Ischemia | 1 | 2015 | 1876 | 0.070 |
Why?
|
Streptococcal Infections | 3 | 2004 | 616 | 0.070 |
Why?
|
Hyperkalemia | 1 | 2008 | 233 | 0.070 |
Why?
|
ROC Curve | 2 | 2015 | 3572 | 0.070 |
Why?
|
Hospitalization | 4 | 2020 | 10715 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 1995 | 2082 | 0.060 |
Why?
|
Cardiotonic Agents | 2 | 2008 | 539 | 0.060 |
Why?
|
Electroencephalography | 3 | 1999 | 6224 | 0.060 |
Why?
|
Alleles | 1 | 2016 | 6909 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2017 | 15879 | 0.060 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15835 | 0.060 |
Why?
|
Sick Sinus Syndrome | 1 | 2004 | 44 | 0.060 |
Why?
|
Mitral Valve Stenosis | 2 | 2013 | 345 | 0.060 |
Why?
|
Decision Making | 2 | 2013 | 3929 | 0.060 |
Why?
|
Acute Disease | 6 | 2018 | 7238 | 0.060 |
Why?
|
Mediastinal Neoplasms | 1 | 2007 | 402 | 0.060 |
Why?
|
Lung Transplantation | 2 | 1994 | 1309 | 0.060 |
Why?
|
Heart Rupture | 1 | 2003 | 21 | 0.060 |
Why?
|
Genotype | 2 | 2016 | 12982 | 0.060 |
Why?
|
Prospective Studies | 13 | 2017 | 54405 | 0.060 |
Why?
|
Shock | 1 | 2006 | 314 | 0.060 |
Why?
|
Animals | 10 | 2017 | 168388 | 0.060 |
Why?
|
Treatment Failure | 1 | 2009 | 2642 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1926 | 0.050 |
Why?
|
Registries | 3 | 2012 | 8223 | 0.050 |
Why?
|
Longevity | 1 | 2011 | 1065 | 0.050 |
Why?
|
Prognosis | 5 | 2018 | 29588 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2373 | 0.050 |
Why?
|
Adolescent | 14 | 2020 | 88305 | 0.050 |
Why?
|
Heart Aneurysm | 1 | 2002 | 114 | 0.050 |
Why?
|
United States | 8 | 2020 | 72317 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5820 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7390 | 0.050 |
Why?
|
Mitral Valve Prolapse | 2 | 1994 | 215 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3638 | 0.050 |
Why?
|
Staphylococcal Infections | 3 | 2004 | 1409 | 0.050 |
Why?
|
Risk | 3 | 2020 | 9605 | 0.050 |
Why?
|
Combined Modality Therapy | 5 | 2007 | 8526 | 0.050 |
Why?
|
Ultrasonography | 2 | 2013 | 5970 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2008 | 5247 | 0.050 |
Why?
|
Rats | 1 | 2017 | 23729 | 0.050 |
Why?
|
Cardioplegic Solutions | 2 | 2018 | 123 | 0.050 |
Why?
|
Arginine | 1 | 2004 | 933 | 0.050 |
Why?
|
Predictive Value of Tests | 6 | 2015 | 15262 | 0.050 |
Why?
|
Anesthesia, General | 2 | 2006 | 1174 | 0.050 |
Why?
|
Catheterization, Peripheral | 3 | 1999 | 342 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4063 | 0.040 |
Why?
|
Pain, Postoperative | 1 | 2011 | 1737 | 0.040 |
Why?
|
Databases as Topic | 2 | 2012 | 473 | 0.040 |
Why?
|
Young Adult | 8 | 2020 | 59196 | 0.040 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1741 | 0.040 |
Why?
|
Angiography | 1 | 2005 | 1599 | 0.040 |
Why?
|
Complement Membrane Attack Complex | 1 | 1999 | 105 | 0.040 |
Why?
|
Complement C5 | 1 | 1999 | 106 | 0.040 |
Why?
|
Coronary Angiography | 3 | 2018 | 4472 | 0.040 |
Why?
|
Incidental Findings | 1 | 2004 | 697 | 0.040 |
Why?
|
Diastole | 2 | 2015 | 782 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4793 | 0.040 |
Why?
|
Massachusetts | 2 | 2011 | 8837 | 0.040 |
Why?
|
Heart | 2 | 2022 | 4405 | 0.040 |
Why?
|
Group IV Phospholipases A2 | 1 | 2019 | 58 | 0.040 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2019 | 90 | 0.040 |
Why?
|
Blood Pressure | 2 | 2013 | 8485 | 0.040 |
Why?
|
Brachiocephalic Trunk | 1 | 1998 | 40 | 0.040 |
Why?
|
Pancreatitis | 1 | 2005 | 1096 | 0.040 |
Why?
|
Surgical Wound Dehiscence | 1 | 1999 | 213 | 0.040 |
Why?
|
Axillary Vein | 1 | 1997 | 14 | 0.040 |
Why?
|
Cardiovascular Agents | 2 | 2016 | 840 | 0.040 |
Why?
|
Cryopreservation | 1 | 2003 | 728 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2022 | 921 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2005 | 7999 | 0.040 |
Why?
|
Cause of Death | 4 | 2010 | 3685 | 0.040 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2018 | 628 | 0.040 |
Why?
|
Genetic Variation | 2 | 2009 | 6571 | 0.040 |
Why?
|
Aortic Rupture | 1 | 2020 | 319 | 0.040 |
Why?
|
Embolism, Paradoxical | 1 | 1997 | 54 | 0.030 |
Why?
|
Femoral Vein | 1 | 1997 | 153 | 0.030 |
Why?
|
Needs Assessment | 1 | 2003 | 1139 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2002 | 1565 | 0.030 |
Why?
|
Restraint, Physical | 1 | 2018 | 187 | 0.030 |
Why?
|
Serum Albumin | 1 | 1999 | 675 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2001 | 2115 | 0.030 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1999 | 480 | 0.030 |
Why?
|
Probability | 3 | 2010 | 2478 | 0.030 |
Why?
|
Linear Models | 3 | 2015 | 5871 | 0.030 |
Why?
|
Catheterization | 2 | 1998 | 1432 | 0.030 |
Why?
|
Cyclic GMP | 1 | 2017 | 395 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2017 | 468 | 0.030 |
Why?
|
Sex Factors | 3 | 2020 | 10551 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17872 | 0.030 |
Why?
|
Adipokines | 1 | 2017 | 310 | 0.030 |
Why?
|
Sulfonamides | 1 | 2004 | 1976 | 0.030 |
Why?
|
Situs Inversus | 1 | 1994 | 63 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2021 | 1738 | 0.030 |
Why?
|
Molecular Biology | 1 | 2018 | 579 | 0.030 |
Why?
|
Thromboembolism | 2 | 1998 | 996 | 0.030 |
Why?
|
Morbidity | 2 | 1999 | 1750 | 0.030 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1997 | 460 | 0.030 |
Why?
|
Membrane Potentials | 1 | 2017 | 1089 | 0.030 |
Why?
|
Carotid Arteries | 1 | 1998 | 941 | 0.030 |
Why?
|
Benchmarking | 1 | 2020 | 1045 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2021 | 12787 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2001 | 10203 | 0.030 |
Why?
|
Safety | 1 | 1998 | 1150 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2010 | 14597 | 0.030 |
Why?
|
Odds Ratio | 4 | 2012 | 9639 | 0.030 |
Why?
|
Cyclosporine | 1 | 1995 | 778 | 0.030 |
Why?
|
Graft Survival | 2 | 2001 | 3818 | 0.030 |
Why?
|
Confidence Intervals | 3 | 2006 | 2927 | 0.030 |
Why?
|
Efficiency | 1 | 2015 | 476 | 0.020 |
Why?
|
Pericardial Effusion | 1 | 1994 | 247 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 1997 | 850 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2009 | 15499 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2017 | 1152 | 0.020 |
Why?
|
Epidemiologic Methods | 2 | 2009 | 1336 | 0.020 |
Why?
|
Cardiac Output | 1 | 1994 | 837 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 1999 | 2385 | 0.020 |
Why?
|
Cold Temperature | 1 | 2015 | 786 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10191 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 527 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4921 | 0.020 |
Why?
|
Base Sequence | 1 | 2022 | 12449 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2022 | 2746 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1633 | 0.020 |
Why?
|
Time | 2 | 2003 | 545 | 0.020 |
Why?
|
Radiotherapy | 1 | 2017 | 1499 | 0.020 |
Why?
|
Prostheses and Implants | 2 | 1994 | 1272 | 0.020 |
Why?
|
Whole Blood Coagulation Time | 1 | 2010 | 30 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9414 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21009 | 0.020 |
Why?
|
Stroke Volume | 5 | 2007 | 5497 | 0.020 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2009 | 43 | 0.020 |
Why?
|
Clinical Enzyme Tests | 1 | 2009 | 115 | 0.020 |
Why?
|
Erythrocyte Transfusion | 2 | 2007 | 565 | 0.020 |
Why?
|
Drug Resistance | 1 | 2015 | 1597 | 0.020 |
Why?
|
Observer Variation | 1 | 1995 | 2605 | 0.020 |
Why?
|
Assisted Circulation | 1 | 2008 | 100 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2018 | 1303 | 0.020 |
Why?
|
Atrial Natriuretic Factor | 1 | 2009 | 350 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2760 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2724 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 1999 | 7045 | 0.020 |
Why?
|
Smoking | 1 | 2004 | 9051 | 0.020 |
Why?
|
Syndrome | 1 | 1994 | 3268 | 0.020 |
Why?
|
Endarterectomy, Carotid | 1 | 1992 | 555 | 0.020 |
Why?
|
Postoperative Care | 2 | 2008 | 1471 | 0.020 |
Why?
|
Heart Rate | 1 | 1998 | 4197 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3267 | 0.020 |
Why?
|
Vena Cava, Superior | 1 | 2007 | 198 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2003 | 14665 | 0.020 |
Why?
|
Creatine Kinase | 2 | 1999 | 686 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2004 | 5841 | 0.020 |
Why?
|
Blood Loss, Surgical | 2 | 1999 | 636 | 0.020 |
Why?
|
Tissue Donors | 1 | 1995 | 2331 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2015 | 1792 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2017 | 3310 | 0.020 |
Why?
|
Genes | 1 | 2009 | 1844 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 1994 | 1324 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 1997 | 3460 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6768 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 2007 | 1122 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4936 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2009 | 1021 | 0.010 |
Why?
|
Isoenzymes | 2 | 1999 | 1688 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1994 | 5491 | 0.010 |
Why?
|
Adenoma | 1 | 1994 | 2159 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5334 | 0.010 |
Why?
|
Prevalence | 2 | 2015 | 15719 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2007 | 13333 | 0.010 |
Why?
|
Regression Analysis | 2 | 2006 | 6341 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2007 | 1682 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20092 | 0.010 |
Why?
|
Vena Cava Filters | 1 | 2005 | 261 | 0.010 |
Why?
|
Europe | 1 | 2009 | 3420 | 0.010 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 1993 | 1461 | 0.010 |
Why?
|
Body Mass Index | 1 | 1999 | 12949 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9605 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8632 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2015 | 3744 | 0.010 |
Why?
|
Electrocardiography | 2 | 2009 | 6382 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2007 | 1110 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3324 | 0.010 |
Why?
|
Prosthesis Fitting | 1 | 1999 | 75 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2005 | 709 | 0.010 |
Why?
|
Single-Chain Antibodies | 1 | 1999 | 111 | 0.010 |
Why?
|
Coronary Stenosis | 1 | 2005 | 794 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2007 | 3588 | 0.010 |
Why?
|
Mediastinum | 1 | 1999 | 267 | 0.010 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1998 | 144 | 0.010 |
Why?
|
Heart Injuries | 1 | 1999 | 206 | 0.010 |
Why?
|
Complement Activation | 1 | 1999 | 452 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10764 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2358 | 0.010 |
Why?
|
Psychological Tests | 1 | 1999 | 640 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1999 | 748 | 0.010 |
Why?
|
Tissue Adhesions | 1 | 1998 | 218 | 0.010 |
Why?
|
Ventricular Function | 1 | 1998 | 406 | 0.010 |
Why?
|
Embolism, Cholesterol | 1 | 1996 | 32 | 0.010 |
Why?
|
Dissection | 1 | 1998 | 298 | 0.010 |
Why?
|
Arteries | 1 | 2001 | 1125 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 1999 | 673 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2010 | 7824 | 0.010 |
Why?
|
Hemostasis, Surgical | 1 | 1996 | 126 | 0.010 |
Why?
|
Lymphokines | 1 | 1999 | 927 | 0.010 |
Why?
|
Remission Induction | 1 | 2001 | 2395 | 0.010 |
Why?
|
Clavicle | 1 | 1997 | 224 | 0.010 |
Why?
|
Peripheral Vascular Diseases | 1 | 1997 | 488 | 0.010 |
Why?
|
Fluoroscopy | 1 | 1998 | 947 | 0.010 |
Why?
|
Stainless Steel | 1 | 1994 | 79 | 0.010 |
Why?
|
Marfan Syndrome | 1 | 1996 | 236 | 0.010 |
Why?
|
Pericardiectomy | 1 | 1994 | 46 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 6966 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23427 | 0.010 |
Why?
|
Patient Care Team | 1 | 2005 | 2523 | 0.010 |
Why?
|
Methods | 1 | 1994 | 1074 | 0.010 |
Why?
|
Ventricular Pressure | 1 | 1994 | 210 | 0.010 |
Why?
|
Stents | 1 | 2005 | 3179 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1997 | 1055 | 0.010 |
Why?
|
Polytetrafluoroethylene | 1 | 1994 | 246 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 1994 | 562 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1994 | 631 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1989 | 4696 | 0.010 |
Why?
|
Sutures | 1 | 1994 | 284 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 22124 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12972 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 1996 | 1516 | 0.010 |
Why?
|
Nutritional Status | 1 | 1999 | 1613 | 0.010 |
Why?
|
Surface Properties | 1 | 1994 | 1160 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1999 | 6231 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1994 | 1495 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 1994 | 1370 | 0.010 |
Why?
|
Echocardiography, Doppler | 1 | 1994 | 898 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81474 | 0.010 |
Why?
|
Neoplasms | 1 | 2018 | 22158 | 0.010 |
Why?
|
Infant | 2 | 2004 | 36202 | 0.000 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 1999 | 3489 | 0.000 |
Why?
|
Interleukin-2 | 1 | 1994 | 1891 | 0.000 |
Why?
|
Polymers | 1 | 1994 | 1614 | 0.000 |
Why?
|
Equipment Design | 1 | 1994 | 3510 | 0.000 |
Why?
|
Chronic Disease | 1 | 1999 | 9319 | 0.000 |
Why?
|
Body Weight | 1 | 1994 | 4614 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 2 | 2007 | 36430 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 9180 | 0.000 |
Why?
|
Graft Rejection | 1 | 1994 | 4446 | 0.000 |
Why?
|
Inflammation | 1 | 1999 | 10760 | 0.000 |
Why?
|
Child, Preschool | 2 | 1994 | 42251 | 0.000 |
Why?
|
Obesity | 1 | 1999 | 12934 | 0.000 |
Why?
|
Child | 1 | 1994 | 80156 | 0.000 |
Why?
|